510(k) K915390

3 LEAD EXTENSION WITH 2 INTERLINK INJECTION SITES by Baxter Healthcare Corp — Product Code FPA

K915390 is an FDA 510(k) premarket notification submitted by Baxter Healthcare Corp for the device "3 LEAD EXTENSION WITH 2 INTERLINK INJECTION SITES". The FDA issued a decision of Substantially Equivalent on Mar 12, 1992. The device falls under product code FPA (Set, Administration, Intravascular), a Class II device regulated under 21 CFR 880.5440. Baxter Healthcare Corp has 507 other 510(k) clearances on record.